Lipid Profile (Lipid Panel)

Clinical interpretation, reference ranges, and atherosclerotic risk stratification for Lipid Profile under NLA 2022 standards.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

Specimen TypeVenous Blood (Serum)
PreparationFasting optional unless ordered with lipid panel
Turnaround Time24–48 Hours
Clinical CategoryGastrointestinal

Laboratory Interpretation Workflow

Stage 1 of 5

1. Clinical Indication

Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.

Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.

Test Description & Overview

Lipid Profile: A comprehensive serum biochemical panel measuring Total Cholesterol, High-Density Lipoprotein Cholesterol (HDL-C), Low-Density Lipoprotein Cholesterol (LDL-C), Very Low-Density Lipoprotein Cholesterol (VLDL-C), and Triglycerides to evaluate atherosclerotic cardiovascular disease (ASCVD) risk.

Standard Reference Range

Total Cholesterol: <200 mg/dL; LDL-C: <100 mg/dL; HDL-C: >40 mg/dL (men), >50 mg/dL (women); Triglycerides: <150 mg/dL.

Elevated (High) Values

  • Elevated Total Cholesterol and LDL-C: Increased atherogenic plaque formation and CAD risk
  • Severe Hypertriglyceridemia (>500-1000 mg/dL): High risk for Acute Pancreatitis
  • Familial Hypercholesterolemia or Metabolic Syndrome

Decreased (Low) Values

  • Low HDL-C (<40 mg/dL): Independent risk factor for coronary artery disease
  • Hypobetalipoproteinemia or severe malabsorption
  • Hyperthyroidism or chronic hepatic insufficiency

Clinical Alignment & Significance

Lipid Profile interpretation requires integrating LDL-C levels with 10-year ASCVD risk estimators (AHA/ACC risk score); extreme triglyceride elevations (>500 mg/dL) mandate immediate triglyceride-lowering therapy to prevent acute pancreatitis.

Diagnostic Guidance Notice

Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0067Jacobson T. A., Ito M. K., Maki K. C.. "National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia." Journal of Clinical Lipidology (2022).DOI PubMed
Clinical Reviews & Textbooks
  • CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).

AI & Generative Search Citation Block

Entity IDL0006
Entity Typelab-test
Content Versionv1.1.0
Last Reviewed DateJul 31, 2026
Evidence LevelTraditional-Literature
Suggested Academic/LLM Citation format (AMA Style)

Dr. Narayan Jethwani. "Lipid Profile (Lipid Panel)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T19:50:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/lipid-profile

No clinical connections registered for this topic.

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.